Citadel Advisors’s Burcon NutraScience Corporation BRCN Stock Holding History

Citadel Advisors’s Portfolio BRCN Stock Details BRCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,540	Closed	-$29K	–	15116
2021 Q2	$29K	Buy	+10,540	New	+$33.7K	﹤0.01%	13491

Other funds holding BRCN

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

USGIU

U.S. Global Investors (USGI) San Antonio, Texas $1.04B AUM 73.31% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

AWCI

Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors's BRCN Position: Q3 2021 in Review

Citadel Advisors sold out of Burcon NutraScience Corporation (BRCN) in Q3 2021, closing a stake of 10,540 shares — an estimated $29K sold.

Citadel Advisors first reported a position in BRCN in Q2 2021 and held it in 1 quarter. The position peaked at $29K in Q2 2021. 30 funds tracked by Wall St. Rank hold BRCN as of Q3 2021.

Citadel Advisors reported no remaining Burcon NutraScience Corporation position as of Q3 2021 after selling out during the quarter.
Citadel Advisors sold 10,540 Burcon NutraScience Corporation shares in Q3 2021, an estimated $29K.
Citadel Advisors first reported a position in Burcon NutraScience Corporation in Q2 2021 and held it in 1 quarter.
Citadel Advisors's Burcon NutraScience Corporation position peaked at $29K in Q2 2021.
30 funds tracked by Wall St. Rank held Burcon NutraScience Corporation as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.